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Abstract
The main purpose of the present study is to envisage the molecular mechanism of inhibitory action ofdehydrocostuslactone
(DCE) andcostunolide (CS), two naturally occurring sesquiterpene lactones, towards the activation of signal transducer and
activator of transcription 3 (STAT3). We report that, in human THP-1 cell line, they inhibit IL-6-elicited tyrosine
phosphorylation of STAT3 and its DNA binding activity with EC50 of 10 mM with concomitantdown-regulation ofthe
phosphorylation of the tyrosine Janus kinases JAK1, JAK2 and Tyk2. Furthermore, these compounds that contain an a-b-
unsatured carbonyl moiety and function as potent Michael reaction acceptor, induce a rapid drop in intracellular
glutathione (GSH) concentration by direct interaction with it, thereby triggering S-glutathionylation of STAT3.
Dehydrocostunolide (HCS), the reduced form of CS lacking only the a-b-unsaturated carbonyl group, fails to exert any
inhibitory action. Finally, the glutathione ethylene ester (GEE), the cell permeable GSH form, reverts the inhibitory action of
DCE and CS on STAT3 tyrosine phosphorylation. We conclude that these two sesquiterpene lactones are able to induce
redox-dependent post-translational modification of cysteine residues of STAT3 protein in order to regulate its function.
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Introduction
The Janus kinases (JAKs) and signal transducers and activators
of transcription (STATs) pathway is responsible for signal
transduction of a large number of cytokines and growth factors
that regulate responses to inflammation or immune challenge and
address the future of cell decision during development and
neoplastic growth [1]. After the cytokines binding to their cognate
receptors, JAK tyrosine kinases, JAK1, JAK2 and Tyk2, are
promptly activated and proceed to tyrosine-phosphorylate cyto-
solic, latent STATs. The phosphorylated STATs homo- or hetero-
dimerize and translocate into the nucleus to regulate expression of
target genes. In addition to tyrosine phosphorylation, STATs are
occasionally phosphorylated on serine residues, located on their
carboxyl-terminal trans-activation domains [2].
Seven STATs proteins have been identified so far. In physiological
conditions STATs activation is transient and usually lasts from a few
minutes to several hours. This is assured by a variety of negatively
acting events thatblock further activation, decrease DNA binding or
result indephosphorylation of STATs. The final outcome of
cytokine/growth factor stimulation reflects how different cell types
can interpret the complex and often contrasting signals they receive.
The pleiotropic cytokine IL-6 activates predominantly STAT3
binding to Gp130 receptor complex and modulate the expression
of genes encoding mediators crucial for the classic physiological
acute phase response and for the apoptotic pathway [3]. Although
tyrosine phosphorylation of STAT3 is accompanied by serine
phosphorylation in a variety of cells, the biologic role of serine
STAT3 phosphorylation is controversial. Some studies suggest
that serine phosphorylation enhances transcriptional activity [4],
whereas other reports demonstrate that serine phosphorylation
induces inhibitory activity [5,6].
Although STAT3 activation normally leads to the physiological
response, deregulation of this transduction cascade could lead to
the tissue damage and directly or indirectly could be involved in
different pathologies. A number of inflammation-correlated
diseases such as Crohn’s disease, pleurisy, psoriasis etc. are
characterized by hyperactivationof STAT3 [7,8,9]. Furthermore
STAT3 is considered as an oncoprotein and its constitutive
activation is reported in numerous solid and haematological
tumours [10]. Therefore, any treatment counteracting the hyper-
expression or -activation of STAT3 has been considered as a new
strategy to treat these world-widely increasing pathologies [11,12].
In this context, the use of naturally occurring compounds,
especially those present in plants, has recently attracted the
attention of many researchers. We recently reported that green tea
extract or epigallocatechin-3-gallate, the main green tea compo-
nent, and hyperforin present in St. John Wort extract exert a
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 strong inhibitory action on IFN-c-elicited STAT1 activation,
indicating the possibility of their use in the prevention/therapy
against stroke and diabetes, respectively [13,14,15].
The cellular redox state is a crucial mediator of multiple
metabolic, signalling and transcriptional processes in cells, and a
fine balance between oxidizing and reducing conditions is essential
fornormalfunctionandsurvivalofcells[16].Thedisturbanceinthe
glutathione/glutathione disulphide couple (GSH/GSSG) homeo-
stasis is implicated in the ethiology and/or progression of a number
of human diseases, including cancer, neurodegenerative diseases,
cystic fibrosis etc. [17]. GSH deficiency manifests itself largely
through an increased susceptibility to oxidative stress, and the
resulting damage is a key step in the onset and progression of many
disease states. Conversely, elevated GSH levels generally increase
antioxidant capacity and resistance to oxidative stress, and this is
observed in many types of cancer cells. Oxidative stress may cause
reversible and/or irreversible oxidative modifications on sensitive
proteins that may lead to a change in their activity or function [18].
Mild oxidative stress induces reversible modifications, including the
glutathionylationofcysteineresidues.Thisreactionmayhavea dual
role: protection from irreversible damageand modulationof protein
function. Conversely, excessive oxidative stress triggers irreversible
modification of thiolic groups of proteins generally associated with
permanent lossoffunction,misfolding and aggregation [19].Recent
report indicates that STAT3 can be glutathionylated under
oxidative conditions with concomitant inhibition of its phosphor-
ylation, thus suggesting the possible cross-talk between these two
post-translational reactions [20].
Dehydrocostuslactone (DCE) and costunolide (CS), two sesquiter-
pene lactones present in a number of plants such as Laurusnobilis L.,
Magnolia sieboldii L. and Sassureacustus L., exhibit various biological and
immunological activity, including antinflammatory and antifungal
one [21,22]. It has also been reported the proapoptotic effect of these
compounds in different human cancer cells [23,24,25,26]. These
compounds exert an inhibitory action on NF-kB pathway [27,28],
induce Nfr2 activation [29,30] and activate many MAP kinases such
as JNK, ERK2 and P38 [23]. Moreover, DCE inhibits the
constitutive STAT3 activation through an increase in suppressor of
cytokine signalling (SOCS)-1 and (SOCS)-3 expression [31].
However, the main target of the molecular mechanism of their
biological action has not been clarified so far.
In the present study we hypothesized that decrease in the
intracellular GSH level, induced by DCE and CS, triggers the
inhibition of STAT3 tyrosine phosphorylation mediated by its
glutathionylation. To evaluate this, we examined the effect of two
terpenes on the activation of STAT3 induced by IL-6 in human
acute monocyticleukemia THP-1 cells. We present data indicating
the direct involvement of GSH deficiency in the inhibition of
STAT3 pathway through the glutathionylation of STAT3.
Materials and Methods
Chemicals
All chemicals used throughout the present study were of the
highest analytical grade, purchased from Sigma Chemical
Company, Milan, Italy, unless otherwise specified. RPMI 1640
medium, Dulbecco’s modified Eagle’s medium (DMEM) and fetal
bovine (FBS) serum were obtained from Lonza, Verviers, BE.
DCE and CS (Figure 1) were purchased from PhytoLab GmbH &
Co, Vestenbergsgreuth, Germany.
Rabbit anti-phospho-Tyr
705STAT3, anti-phospho-Ser
727STAT3,
anti-phospho-Tyr
1054/55TyK2 and anti-JAK2 were purchased from
Cell Signaling Technology, Beverly, MA; rabbit anti-phospho-
Tyr
1022/1023JAK1 and anti-phospho-Tyr
1007/1008JAK2 antibodies
were obtained fromMillipore, Bedford, MA; rabbit anti-SOCS-3 was
from ImmunoBiological Laboratories, Tokyo, Japan; rabbit anti-
STAT3, anti-Tyk2 and anti-JAK1 antibodies werefrom Santa Cruz
Biotechnology, Inc., Santa Cruz, CA.
Cell culture
Human monocyticleukemia THP-1 cells (American Type
Culture Collection, Manassas, VA) were cultured in RPMI 1640
supplemented with 10% FBS, 100 UI/ml penicillin, 100 mg/ml
streptomycin and 40 mg/ml gentamycin in a 5% CO2 atmosphere
at 37uC. Human cervical carcinoma HeLa cells (American Type
Culture Collection) and human colorectal adenocarcinoma DLD-
1 cells (American Type Culture Collection) were cultured in
DMEM supplemented with 10% FBS under the same conditions.
Construction of Tyk2
Tyk2 was amplified by PCR with the following primer sets:
59-CGGAATTCATGCCTCTGCGCCACTGG-39 (sense)
59-ACGCGGCCGCTCAGCACACGCTGAACAC-39 (anti-
sense).
PCR primers included 59-NotI, 59-EcoRI restriction sites
(boldface) to aid cloning. PCR products were digested completely
Figure 1. Structure of Dehydrocostuslactone (DCE), Costunolide (CS) and Dehydrocostunolide (HCS). The a-b-unsaturated carbonyl
group is marked with a dotted circle.
doi:10.1371/journal.pone.0020174.g001
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pcDNA 3.0 to give Tyk2-pcDNA 3.0. The nucleotide sequence of
this expression plasmid was verified by DNA sequencing.
Cells transfection
For a transient transfection, HeLa cells were plated into 60-mm
plates at a density of 8610
5 in DMEM without antibiotics. After
18 hours, the DMEM was replaced with the serum-reduced
medium OPTI-MEM (Invitrogen, Carlsbad, CA) and the cells
were transfected with 1 mg Tyk2-pcDNA 3.0 expression vector
and 10 mllipofectamine 2000 according to the manufacturer’s
instructions (Invitrogen, Carlsbad, CA). After 24 hours, the cells
were treated with IL-6 (20 ng/ml) for 5 minutes in order to
achieve Tyk2 activation. Effect of two terpenes on TyK2
activation was examined by treating cells for 30 minutes before
IL-6 stimulation. The cells were harvested and used for Western
blot analysis.
Electrophoretic Mobility Shift Assay-EMSA
3610
6 THP-1 or DLD-1 cells, after 4 hours starvation, were
treated with IL-6 (20 ng/ml) for 15 minutes in order to achieve
STAT3 activation. Effect of two terpenes on STAT3 activation
was examined by treating cells for 30 minutes before IL-6
stimulation. Nuclear extracts of THP-1 cells were prepared
according to Osborn et al. [32] in the presence of 10 mg/ml
leupeptin, 5 mg/ml antipain, 5 mg/ml pepstatin, and 1 mM
phenylmethylsulfonyl fluoride. Eight micrograms of nuclear
extract were incubated with 2–5610
4 cpm of
32P-labeled
double-stranded oligonucleotides, the consensus STAT3 DNA
binding site (sis-inducible factor-binding recognition element,
SIE/m67) from the c-fos promoter (59-gtcgaCATTTCCCG-
TAAATCg-39), in a 15 ml reaction mixture containing 20 mM
Hepes, pH 7.9, 50 mM KCl, 0.5 m Mdithiothreitol, 0.1 mM
EDTA, 2 mg of poly(dI-dC), 1 mg of salmon sperm DNA, and 10%
glycerol. Products were fractionated on a non-denaturing 5%
polyacrylamidegel. The gels were dried and autoradiographed and
the intensity of hybridization was quantified using the public
domain NIH Image 1.61 program (developed at the U.S. National
Institutes of Health and available on http://rsb.info.nih.gov/nih-
image/). Supershift assay was performed by incubating the nuclear
extracts in a binding buffer for 1 hour at 4uC with 1 ml of antibody
before addition of labelled oligonucleotide.
Western blot analysis
Cells, treated as described above, were homogenized at 4uCi n
20 mM HEPES, pH 7.4, containing 420 mM NaCl, 1 mM
EDTA, 1 mM EGTA, 1% Nonidet-P40 (NP-40), 20% glycerol,
protease cocktail inhibitors (GE Healthcare, Amersham Place,
UK) and phosphatase cocktail inhibitors. Aliquots of the cell
lysate (40 mg total protein/lane) were loaded on 7.5% SDS-
polyacrylamide gels. Electrophoresis was performed at 100 V
with a running buffer containing 0.25 M TrisHCl, pH 8.3,
1.92 M glycine, and 1% SDS. The resolved protein were
electroblotted onto a PVDF membrane (Immobilon P, Millipore,
Bedford MA) and incubated overnight at 4uC with the indicated
primary antibodies. After washing, membraneswere developed
using anti-rabbit or anti-mouse IgG peroxidase-conjugated
antibody (Cell Signaling Technology) and chemiluminescent
detection system (Immun-Star
TM WesternC
TM Kit, Bio-Rad,
Hercules, CA). Blotted proteins were detected and quantified
using the ChemiDoc XRS Imaging System (Bio-Rad, Hercules,
CA). After stripping, membranes were re-hybridized with the
correspondent antibodies.
GSH and GSSG recycling assay
The intracellular oxidized and reduced glutathione were
determinedspectrophotometrically using the GSH recycling meth-
od as previously described [33]. Briefly, treated and untreated cells
werelysed by freezing and thawing in 100 mM sodium phosphate
buffer, pH 7.5, containing 5 mM EDTA, (KPE buffer) and after
centrifugation at 16,000 rpm for 10 minutes, total protein
concentration was determined by using Bradford method [34].
The supernatant was removed and deproteinized with 5%
trichloroacetic acid (TCA). For total GSH measurement
(GSH+GSSG), sample aliquot of TCA extract was incubated in
1 ml of KPE buffer containing 0.6 mM 5,59-dithio-bis-(2-nitro-
benzoic acid) (DTNB) and 1 U/ml GSH reductase. The reaction
was startedby the addition of 0.2 mM NADPH and the increase in
absorbance at 412 nm was measured. The amount of total GSH
was determined by comparison with GSH standard curve. For the
determination of GSSG, the same DTNB recycling assay was
performed after using 2-vinylpiyridine to remove the reduced
GSH. Briefly, 2 ml of 2-vinylpiyridine and 4 ml of triethanolamine
were mixed with 100 ml of TCA extract, followed by incubation in
the dark at room temperature for 1 h before initiation of recycling
assay. The increment in absorbance was converted to GSSG
concentration using a GSSG standard curve. The GSH levels were
calculated by subtracting the amount of GSSG formed from total
GSH content obtained. The values were expressed as nmols
GSH/mg protein.
Detection of intracellular reactive oxigen species (ROS)
THP-1 cells resuspended in HBSS (Invitrogen, Carlsbad, CA) at
5610
5/mL were loaded with 2.5 mM of the membrane-permeable
probe 5-(and-6)-chloromethyl-2979-dichlorodihydrofluorescein di-
acetate acetyl ester (CM-H2DCFDA, Molecular Probes, Eugene,
OR) for 1 hour at 37uC. They were then washed with HBSS and
stimulated with 6, 12, 25 mM DCE or CS or 500 mM diamide
(positive control) and placed back into the incubator. After
30 minutes or 1 hour they were washed and resuspended in PBS.
ROS generation was evaluated in flow cytometry (FACSCalibur;
Becton Dickinson, San Jose, CA) by measuring the green
fluorescence signal of DCF, the oxidation product of CM-
H2DCFDA by free radicals. The emitted fluorescence was
detected in Fl-1 using a 530/30 nm band-pass optical filter.
FlowJo 8.8.2 software (Tree Star, Ashland, OR) was used to
analyze data.
HPLC analysis
10 mM DCE and CS were incubated with 5, 25 and 100 mM
GSH in RPMI medium without FBS, at 37uC for 30 minutes and
analysed by HPLC (Shimadzu, Kyoto, JP).
The reaction mixtures were charged on Mightysil RP-18 GP
reverse-phase column, (150 mm64.6 mm, Kanto Chemical,
Tokyo, JP) maintained at 35uC and eluted with 35% acetonitrile
at a flow rate of 1.0 ml/min. The elution profiles were monitored
at 215 nm by UV detector. Retention times of DCE and CS peaks
were 7.3 and 8.1 minutes, respectively.
Immunoprecipitation and identification of
glutathioylated proteins
Cells were lysed in RIPA buffer (20 mM TrisHCl, pH 8.0,
150 mM NaCl, 1% (wt/vol)Nonidet P-40, 1 mM EDTA, 10%
glycerol, 100 mM NaF, 1 mM Na3VO4) supplemented with
protease cocktail inhibitor for 15 minutes on ice with occasional
vortexing. Equal amounts of proteins from the clarified cell lysates
were incubated overnightat 4uC with rotation in the presence of
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addition of protein A sepharose (Millipore Corp.), washed
extensively, eluted in a non-reducing sample buffer (62.5 mM
TrisHCl, pH 6.8, 10% glycerol, 5% SDS, 0.05% bromophenol
blue) and separated on a 5% SDS–polyacrylamide gel. After
electrophoresis, proteins were transferred to a PVDF membrane
and nonspecific binding was blocked by incubation in 3% BSA
diluted in TBST. Membranes were then probed with primary
monoclonal antibodies against GSH (ViroGen, Watertown, MA)
or STAT3. After washing, blots were incubated with anti-rabbit
IgG peroxidase-conjugated antibody (Cell Signaling Technology).
Protein-antibody reactions were detected with chemiluminescent
detection system (Immun-Star
TM WesternC
TM Kit, Bio-Rad). The
S-glutathionylated proteins on membranes were detected and
quantified using the ChemiDoc XRS Imaging System (Bio Rad).
Statistical analysis
Data are reported as means 6 SD of four independent
experiments (n=4); statistical analyses were performed using
Student’s t test. Differences were considered significant
whenp#0.05.
Results
DCE and CS exert an inhibitory action on IL-6-elicited
STAT3 in THP-1 cells
In order to evaluate the effect of DCE and CS on STAT3
signalling pathway, EMSA and Western blot analysis were
performed in THP-1 cells treated with IL-6 (20 ng/ml) for
15 minutes. IL-6 increased predominantly the STAT3 DNA-
binding activity, as indicated by EMSA/supershift experiment
with anti-STAT3 antibody in line with previous report (Figure 2a).
The administration of DCE and CS up to 25 mM 30 minutes
before IL-6 treatment was able to inhibit in a concentration-
dependent manner STAT3 DNA-binding activity with estimated
EC50 value of 10 mM. (Figure 2a).
One of the critical steps leading to the activation of STAT3 is its
phosphorylation on specific tyrosine residue and successive
Figure 2. Effect of DCE and CS on IL-6-elicited STAT3 activation in THP-1 cells. (a) EMSA shows that DCE and CS dose-dependently
decrease DNA-binding activity of STAT3 activated by 20 ng/ml IL6 in THP-1 cells. In the insert EMSA/supershift indicates that IL-6 induces prevalently
the activation of STAT3. (b) Western Blot analysis shows that DCE and CS dose-dependently decrease tyrosine
705 phosphorylation of STAT3 induced
by 20 ng/ml IL-6 in THP-1 cells without changing the total amount of STAT3. Furthermore the sesquiterpens don’t affect serine
727 phosphorylation.
The gels are representative of four independent experiments.
doi:10.1371/journal.pone.0020174.g002
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Western Blot analysis showed that DCE and CS decreased, in a
dose-dependent manner, IL-6-induced tyrosine
705 phosphoryla-
tion of cytosolic STAT3 without affecting the total amount of
STAT3 protein (Figure 2b). In addition to tyrosine phosphoryla-
tion, STAT3 is also phosphorylated on serine
727 residue; as for
others hematological cell line [35], also in THP-1 cells STAT3 is
constitutively phosphorylated on serine residue and IL-6 only
slightly induced it. DCE as well as CS were not able to modulate it
(Figure 2b).
DCE and CS were also able to down modulate IL-6 dependent-
tyrosine phosphorylation of STAT3 and its DNA binding activity
in DLD-1 cell line (Figure S1).
DCE and CS are able to inhibit IL-6-elicited JAKs
phosphorylation
The ability of DCE and CS to suppress the tyrosine
phosphorylation of STAT3 suggests that these compounds may
interfere with the function of upstream tyrosine kinases JAKs
associated to the cytoplasmic portion of IL-6-receptor [36,37].
Thus, we determined the effect of these terpenes on IL-6–induce
tyrosine phosphorylation of JAK1 and JAK2 in THP-1 cells by
Western Blot using antibodies that specifically recognizes phospho-
Tyr
1022/1023JAK1 and phospho-Tyr
1007/1008JAK2. IL-6 induced
the tyrosine-phosphorylation of both JAK1 and JAK2 in
10 minutes; notably, pre-treatment with 6–25 mM DCE or CS
for 30 minutes resulted in almost complete dephosphorylation of
both kinases. No change in total JAKs levels was observed
(Figure 3a). Similar results were obtained in DLD-1 cell line
(Figure S1). In order to analyse the effect of these terpenes on
tyrosine
1054/1055-phosphorylation of Tyk2, we used HeLa cell line
transfected with Tyk2 expression plasmid. Western blot analysis
showed that 6–25 mM DCE or CS induced almost complete
dephosphorylation of IL-6-elicited Tyk2 in 30 minutes (Figure 3b).
Previous report described the inhibitory effect of DCE on
constitutive STAT3 activation mediated by an increase in
suppressor of cytokine signalling (SOCS) expression [31].
Treatment of THP-1 cells with 6–25 mM DCE or CS for
30 minutes to 1 hour had no impact on SOCS-3 expression (data
not shown).
Inhibition of the IL-6-elicited phosphorylation of STAT3
by DCE and CS is triggered by the drop in intracellular
GSH level
In order to envisage the molecular mechanism of the inhibitory
action of DCE and CS on STAT3 phosphorylation, we further
hypothesized that the change in intracellular GSH level may play
a critical role.
Spectrophotometric analysis measuring GSH and GSSG
concentrations in THP-1 cells showed that under normal
conditions the amounts of GSH (1360.8 nmoles/mg protein)
are far higher than those of GSSG (0.0960.02 nmoles/mg
protein) and that DCE and CS induced dose- and time-
dependently the drop in GSH concentration, only slightly affecting
GSSG level (Figure 4). The rapid drop in intracellular GSH
amount is timely compatible with the inhibition of STAT3
phosphorylation.
To evaluate whether this event is crucial in the modulation of
STAT3 pathway, THP-1 cells were pre-treated overnight with
1 mM glutathione monoethyl ester (GEE), the cell permeable
GSH, and thereafter with the two sesquiterpene lactones up to
25 mM for 30 minutes before IL-6 administration. Western blot
analysis showed that GEE reverts tyrosine-phosphorylation of
STAT3 and this effect is correlated with the administrated
sesquiterpenes’ concentration (Figure 5). Also in DLD-1 cells, this
post-translational modification is dependent on intracellular GSH
concentration (Figure S1).
All these data further suggest the critical role played by
intracellular GSH level in regulating IL-6-elicited-STAT3 activa-
tion.
DCE and CS induce ROS production
THP-1 cells loaded with CM-H2DCFDA and treated with DCE
or CS exhibited a clear fluorescence increase as respect to
untreated sample. This data is consistent with an enhancement of
intracellular ROS. Figure 6 shows that this effect is time-
dependent but not dose-dependent. Indeed fluorescence intensity
was similar at the different concentrations of the two compounds
at the same time starting from 30 minutes to 1 hour stimulation.
Likewise, diamide, a strong oxidant compound used as positive
control, gave a time-dependent effect (inset).
DCE and CS are able to directly interact with GSH
Previous works reported that some sesquiterpene lactones
including CS, decrease the intracellular thiols level, without clear
demonstration of the direct bond formation between them [24,38].
HPLC analysis of the solutions containing the sesquiterpene
lactones plus GSH, prepared as described under Material and
Methods, showed that the amounts of these terpenes decrease in
the presence of increasing concentration of GSH, indicating their
Figure 3. Effect of DCE and CS on tyrosine phosphorylation of
JAK tyrosine kinases. Western Blot analysis shows that DCE and CS
dose-dependentlydecreasetyrosine
1022/1023 phosphorylation of JAK1
and tyrosine
1007/1008 phosphorylation of JAK2 in THP-1 cells (a) and
dose-dependently decreasetyrosine
1054/1055 phosphorylation of Tyk2 in
HeLa cells transiently transfected with Tyk2-pcDNA 3.0 (b). The
compounds don’t change the total amount of the corresponding
non-phosphorylated proteins. The gelsarerepresentatives of four
experiments performed separately.
doi:10.1371/journal.pone.0020174.g003
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intracellular GSH levels induced by DCE and CS may be
mediated, at least partly, by this interaction.
DCE and CS, that contain an a-b-unsatured carbonyl moiety,
function as potent Michael reaction acceptor. To analyze the
importance of this group in the inhibitory action of these
sesquiterpene lactones, we examined the effect of dehydrocostu-
nolide (HCS), the reduced form of CS (Figure 1), on IL-6-elicited
STAT3 phosphorylation. Contrary to DCE and CS, HCSfailed to
exert any inhibitory action (Figure 7b).
DCE and CS induce the S-glutathionylation of STAT3
interfering with its phosphorylation
A recent report describes that the strong oxidant diamide
elicited S-glutathionylation of STAT3 leading to the inhibition of
its tyrosine phosphorylation [20]. This post-translational modifi-
cation may represent the mechanism of regulation of STAT3
activity in cells treated with DCE and CS.
As shown in Figure 8, the anti-glutathione antibody
recognizes STAT3 immunoprecipitated proteins in THP-1 cells
treated with 12–50 mMD C Ea n dC Sa sw e l la sw i t h5 0 0mM
diamide for 30 minutes, suggesting that these two sesquiterpene
lactones induce dose-dependently the glutathionylation of
STAT3. The blots exhibited equivalent STAT3 protein levels
in all samples.
Discussion
Receptor-associated JAK family tyrosine kinases, JAK1, JAK2
and Tyk2, plays a crucial role in the STATs signal transduction
pathway activated by a number of cytokines and growth factors.
Following the binding of these ligands to their specific membrane
receptors, JAK kinases associated to cytoplasmic portion of
receptors, tyrosine phosphorylate themselves and successively
STAT proteins. Although this signalling pathway is finely
regulated to guarantee the physiological response, hyper-activation
of STATs has often been observed in a number of pathologies,
especially that of STAT3 in cancer and in some inflammatory
diseases. Therefore, attention has recently been paid to the
compounds able to modulate STAT3 pathway in order to alleviate
the detrimental effect of its hyper-activation.
Figure 4. DCE and CS decrease intracellular GSH level in THP-1 cells. DCE and CS time- and dose-dependently induce the drop in cellular
GSH content without significantly affecting the amounts of GSSG. Data are presented as means 6 SD of results from four independent experiments.
Significant difference compared to control group (*p#0.05).
doi:10.1371/journal.pone.0020174.g004
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occurring sesquiterpene lactones, DCE and CS, as inhibitors of IL-
6-elicited STAT3 activationin human cell line THP-1
(EC50=10mM) and demonstrates that DCE and CS rapidly
suppress cytokine-induced tyrosine-phosphorylation of JAK1,
JAK2 and Tyk2.
Previous report described the inhibitory effect of DCE on
constitutive STAT3 activation mediated by an increase in SOCS
expression [31]. The different proteins targeted by the same
compound may reflect the diverse mode of activation of cytokines-
induced and constitutively activated STAT3. In THP-1 cells, DCE
and CS weren’t able to modify the expression of SOCS-3 (data not
shown). The rapid STAT3 inhibitory action showed herein seems
to be more compatible with the notion that JAK family proteins,
instead of SOCS-3, are their main target since the inhibition of the
phosphorylation of pre-existing kinases may require far less time
than de novo synthesis of SOCS-3 protein.
An increasing body of literature evidences underlines the critical
involvement of intracellular redox state in cancer and in
inflammation-associated diseases. Under normal conditions,
mammalian cells contain 1–10 mM cytosolic GSH, depending
on cell type and metabolic factors. GSH represents approxima-
tively 95% of total non proteinthiols and is the main modulator of
the cellular redox environment. The cytoplasmic high ratio
between the reduced and oxidized glutathione (GSH/GSSG) is
a key factor in keeping the cysteine residues of intracellular
proteins in the reduced form. The decrease in GSH content,
leading to the drop in the cellular redox potential, is often induced
by oxidative stress. In the present study we show that, in line with
above-described notion, in THP-1 cells GSH content is far higher
than GSSG and that DCE and CS dose-dependently induce the
consistent drop in intracellular GSH level without significantly
affecting GSSG content (Figure 4). The drop in GSH content is
timely compatible with the data on rapid inhibition of STAT3
phosphorylation by these compounds (Figure 4 and 2). The
decrease in GSH concentration may be due to their ability both to
generate oxygen species (ROS) [25,26] and to interact with GSH.
Data presented in Figure 6 show that DCE and CS induce time-
dependent but not dose-dependent ROS production in THP-1
cells, suggesting that the drop in GSH content induced by these
two compounds maybe due, at least in part, to their capacity to
increase ROS production, in line with literature evidences [25,26].
Results in Figure 7a furthermore indicate that DCE and CS are
Figure 5. GEE reverts the inhibitory action of DCE and CS on
the IL-6-elicited phosphorylation of STAT3. (a) Western Blot
analysis shows that inhibitory action of DCE and CS on IL-6 induced
STAT3 Tyr
705 phosphorylation is reverted by 1 mM glutathione
monoethyl ester (GEE). The total amount of STAT3 is not affected
during the experiments. The gels are representative of four experiments
performed separately.
doi:10.1371/journal.pone.0020174.g005
Figure 6. DCE and CS induce ROS production. Flow cytometric
analysis of intracellular ROS generation. THP-1 cells loaded with CM-
H2DCFDA and treated for 30 minutes (dark gray) and 1 hour (light gray)
with 6, 12 and 25 mM (a) DCE or (b) CS shows and increment of
fluorescence as respect to untreated cells (white). This increment is
time-dependent but not dose-dependent. 500 mM diamide was used as
positive control (inset). One representative experiment out of four is
depicted.
doi:10.1371/journal.pone.0020174.g006
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shown to be highly efficient under our experimental conditions, it
is supposed that two lactones elicit the rapid drop in the
intracellular GSH content mainly through their capacity to
interact with it.
The direct interaction between DCE or CS and GSH may be
chemically mediated by the a-b-unsaturated carbonyl group
present in their moiety (Figure 1), as described for others
sesquiterpene lactones [39,40]. This structural element may react
with nucleophiles, such as cysteine sulfhydryl groups of cytosolic
proteins, by a Michael-type addition, eventually leading to a mild
electrophilic stress. Indeed, HCS, a structural analogue of CS
lacking only the a-b-unsaturated carbonyl group (Figure 1), has
failed to exert inhibitory action toward STAT3 tyrosine
phosphorylation (Figure 7b), indicating that this terpenes’
unsaturation may play a pivotal role in its biochemical activity.
Furthermore, glutathione monoethyl ester (GEE), cell permeable
form of GSH, reverts the inhibitory effect of these two
sesquiterpene lactones on STAT3 phosphorylation (Figure 5),
suggesting that their action is strictly correlated to the decrease in
intracellular GSH concentration.
The disturbance in the GSH/GSSG homeostasis is implicated
in the induction of reversibileS-glutathionylation of cysteine
residues of sensitive proteins [18,19]. Recently, STAT3 has been
shown to be S-glutathionylated with concomitant loss of its
phosphorylation in HepG2 cells treated with diamide, a strong
oxidant compound, pointing out that this signal transcription
factor is susceptible to redox regulation [20].
The present study showed that DCE and CS induce rapid S-
glutathionylation of STAT3 with concomitant decrease in STAT3
tyrosine phosphorylation (Figure 8 and 2b). Since the S-
glutathionylation of STAT3 induced by them is comparable to
that induced by the strong oxidant, diamide [20] and the
inhibition of STAT3 phosphorylation is reverted when cells are
incubated with GEE (Figure 5), S-glutathionylation of STAT3 is
likely to be triggered by increased oxidative stress induced by the
decrease in GSH content. Although data presented in this study
did not indicate the involvement of GSSG in this scenario due
principally to the very low intracellular level of GSSG (Figure 4),
its critical role in the glutathionylation of STAT3 cannot be
excluded. To our knowledge, S-glutathionylation of STAT3
induced by naturally occurring phytocompounds has never been
described so far.
We conclude that DCE and CS induce time- and dose-
dependent drop in intracellular GSH content and consequently
inhibit the tyrosine-phosphorylation of STAT3 in cells treated
with IL-6. Enhanced oxidative pressure elicited either by direct
interaction with GSH or by ROS generation may trigger an
efficient STAT3 S-glutathionylation with concomitant decrease in
tyrosine705 phosphorylation of STAT3. Dual action on STAT3
activation triggered, on the one hand, by the inhibition of JAKs
catalytic activity that alone may lead to the decrease in STAT3
phosphorylation and, on the other hand, by S-glutathionylation of
STAT3 that may lead to further interference on STAT3
phosphorylation seems to be compatible with an efficient action
of DCE and CS.
Finally, considering the recent notion that STAT3 is a
promising drug target in cancer prevention and/or therapy, the
present work provides a base for the further structure/function
study necessary for the future design/synthesis of DCE and CS-
related compounds with stronger activity.
Supporting Information
Figure S1 Effect of DCE and CS on STAT3 activation in
DLD-1 cells. (a) EMSA shows that DCE and CS dose-
dependently decrease DNA-binding activity of STAT3 activated
by 20 ng/ml IL6 in DLD-1 cells. (b) Western Blot analysis shows
that DCE and CS dose-dependently decrease tyrosine
705 phos-
phorylation of STAT3 induced by 20 ng/ml IL-6 in DLD-1 cells
without changing the total amount of STAT3. (c) DCE and CS
slightly decrease tyrosine
1022/1023 phosphorylation of JAK1 and
tyrosine
1007/1008 phosphorylation of JAK2 in DLD-1 cells. (d)
Figure 7. DCE and CS directly interact with GSH. (a) HPLC analysis
shows that GSH dose-dependently decrease the amounts of DCE and
CS after 30 minutes of incubation at 37uC. (Standard deviation of date
obtained from three independent experiments is shown). (b) Western
Blot analysis shows that HCS, is not able to decrease IL-6 induced STAT3
Tyr
705 phosphorylation as CS does in THP-1 cells. The total amounts of
STAT3 are not affected during the experiments. Data are the
representatives of four experiments performed separately. The gels
are representative of four experiments performed separately.
doi:10.1371/journal.pone.0020174.g007
Figure 8. Effect of DCE and CS on glutathionylation of STAT3 in
THP-1 cells. Western Blot analysis of immunoprecipitated STAT3 (IP
STAT3) shows that DCE and CS dose-dependently increase the amounts
of glutathionylated STAT3. At 50 mM both lactones induce the same
level of STAT3 glutathionylation as that induced by 500 mM diamide, a
strong oxidant. The total amounts of STAT3 are not affecting during the
experiments. The gels are representative of four experiments performed
separately.
doi:10.1371/journal.pone.0020174.g008
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on IL-6 induced STAT3 Tyr
705 phosphorylation is reverted by
1 mM glutathione monoethyl ester (GEE). The total amount of
STAT3 is not affected during the experiments.
(TIF)
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